Skip to main navigation Skip to search Skip to main content

Utility of the VDRL test in HIV-seropositive patients

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: The Venereal Disease Research Laboratory (VDRL) and other nontreponemal tests for syphilis measure the levels of antibody directed against a cardiolipin—lecithin antigen. False positive reactions can occur in patients with immunoglobulin abnormalities. Patients infected with the human immunodeficiency virus (HIV) often have polyclonal gammopathy, and a majority have anticardiolipin antibodies.1 False positive nontreponemal tests in patients with HIV make it difficult to evaluate the response to therapy in patients who have syphilis, as exemplified by the following case report. A 61-year-old man with a history of heterosexual promiscuity and syphilis treated in the 1950s presented with hairy.

Original languageEnglish (US)
Pages (from-to)271
Number of pages1
JournalNew England Journal of Medicine
Volume322
Issue number4
DOIs
StatePublished - Jan 25 1990

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Utility of the VDRL test in HIV-seropositive patients'. Together they form a unique fingerprint.

Cite this